CompletedNCT00401089
Official study titleA Placebo-controlled Cross Study of Panax Ginseng in Augmentation of Antipsychotics in 60 Partially Treatment Responsive Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including KingstonSchizophreniaMedication studyAges 18–65
- Countries
- Canada, United Kingdom
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
CompletedNCT05712928
Official study titleThe Effects of Telehealth Dance/Movement Therapy on People With Chronic Schizophrenia
This study has finished and is no longer accepting participants.
In PhiladelphiaSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Drexel University
CompletedNCT02267070
This study has finished and is no longer accepting participants.
In Los AngelesSchizophreniaBehavioural studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT02334280
This study has finished and is no longer accepting participants.
Multiple locations, including LebanonSchizophrenia, BipolarityBehavioural studyAges 21+
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
CompletedNCT00545467
Official study titleEvaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents: Combination of Pharmacogenomics and Therapeutic Drug Monitoring
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT01092598
Official study titleThe Impact of Neurocognition and Symptomatology on Physical Function Among Older Adults With Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaObservational studyAges 55+
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT00434980
Official study titlePilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BostonSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
CompletedNCT00237796
Official study titleFunctional Rehabilitation of Older Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San DiegoSchizophreniaBehavioural studyAges 45+
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
TerminatedNCT02234752
Official study titleA Proof-of Concept Trial of Galantamine and Memantine for Cognitive Impairments in Schizophrenia: Is the Combination Effective?
This study ended early.
In BaltimoreSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Sheppard Pratt Health System
CompletedNCT00108199
This study has finished and is no longer accepting participants.
In BaltimoreSchizophreniaBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
CompletedISRCTN19638644
Official study titleHow Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs
This study has finished and is no longer accepting participants.
In MünchenSchizophreniaBehavioral
- Countries
- Germany
- Sponsor
- Technical University of Munich
CompletedNCT00406718
Official study titleInterventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
This study has finished and is no longer accepting participants.
In San AntonioSchizophreniaBehavioural studyAges 18–60
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center at San Antonio